ImStem, UConn Obtain US Patent for Mesenchymal Stem Cell Technology to Treat MS, Other Diseases – Multiple Sclerosis News Today
Multiple Sclerosis News TodayImStem, UConn Obtain US Patent for Mesenchymal Stem Cell Technology to Treat MS, Other DiseasesMultiple Sclerosis News TodayThe U.S. Patent and Trademark Office has issued a patent for human embryonic stem cells derived mes… Continue reading
